Boston Scientific (NYSE: BSX) announced today that it initiated a new trial to assess its Agent DCB compared to the standard ...

Method AI announced today that it raised $20 million in Series A funding to support its novel surgical ultrasound platform. The Boston-based company, co-founded by former Corindus COO Doug Teany, who ...

Zeiss Medical Technology announced today that it received CE mark approval for its Cirrus PathFinder clinical support tool.

BrainsWay (Nasdaq:BWAY) announced today that it closed an initial strategic investment of $5 million in Neurolief.

Biobeat Technologies announced today that it appointed Raymond W. Cohen as the new chair of its board of directors.